American Healthcare REIT (AHR) Cash & Equivalents (2016 - 2026)

American Healthcare REIT's Cash & Equivalents history runs 11 years deep, the most recent figure standing at $156.9 million for Q1 2026.

• Quarterly Cash & Equivalents rose 23.09% year-over-year to $156.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $156.9 million (up 23.09% YoY) and the FY2025 annual result came in at $151.8 million, up 23.08% from the prior year.
• Cash & Equivalents was $156.9 million for Q1 2026 at American Healthcare REIT, up from $151.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $184.4 million in Q3 2025 and bottomed at $35.2 million in Q3 2023.
• A 5-year average of $95.1 million and a median of $79.4 million in 2022 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents plunged 55.71% — and 2024, when it surged 231.66%.
• American Healthcare REIT's Cash & Equivalents stood at $65.1 million in 2022, then surged by 39.55% to $90.8 million in 2023, then surged by 35.82% to $123.3 million in 2024, then increased by 23.08% to $151.8 million in 2025, then rose by 3.38% to $156.9 million in 2026.
• Business Quant data shows AHR's Cash & Equivalents at $156.9 million in Q1 2026, $151.8 million in Q4 2025, and $184.4 million in Q3 2025.